AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12324672 — intervention group
Group type: EXPERIMENTAL
Intervention: BEC‐HFA 1000 micro g/day
Number of subjects: 20
Study 12324672 — intervention group
Group type: EXPERIMENTAL
Intervention: FLU‐HFA 500 micro g/day
Number of subjects: 20
Study 12324672 — intervention group
Group type: EXPERIMENTAL
Intervention: FLU‐HFA 1000 micro g/day
Number of subjects: 20
Study 11776508 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of GnRH antagonist (Cetrotide)
Number of subjects: 25
Study 11776508 — intervention group
Group type: COMPARATOR
Intervention: Single dose of GnRH antagonist (Cetrotide)
Number of subjects: 25
Study 9438891 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. ondansetron 0.05 mg/kg
Number of subjects: 320
Study 9438891 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. ondansetron 0.1 mg/kg
Number of subjects: 320
Study 9438891 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. ondansetron 0.15 mg/kg
Number of subjects: 320
Study 9438891 — intervention group
Group type: EXPERIMENTAL
Intervention: oral metoclopramide 0.15 mg/kg + i.v. ondansetron 0.05 mg/kg
Number of subjects: 320
Study 9438891 — intervention group
Group type: EXPERIMENTAL
Intervention: oral metoclopramide 0.15 mg/kg + i.v. ondansetron 0.1 mg/kg
Number of subjects: 320
Study 9438891 — intervention group
Group type: EXPERIMENTAL
Intervention: oral metoclopramide 0.15 mg/kg + i.v. ondansetron 0.15 mg/kg
Number of subjects: 320
Study 9438891 — intervention group
Group type: COMPARATOR
Intervention: i.v. saline (placebo)
Number of subjects: 320
Study 8339493 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral external skeletal fixation with micromovement module
Number of subjects: 45
Study 8339493 — intervention group
Group type: COMPARATOR
Intervention: Unilateral external skeletal fixation without micromovement module
Number of subjects: 45
Study 8339493 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight bearing during treatment
Number of subjects: 45
Study 8339493 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback mechanism
Number of subjects: 45
Study 3530094 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract
Number of subjects: 259
Study 3530094 — intervention group
Group type: EXPERIMENTAL
Intervention: almitrine‐raubasine
Number of subjects: 259
Study 3530094 — intervention group
Group type: EXPERIMENTAL
Intervention: nicergoline
Number of subjects: 259
Study 29956424 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS applied to the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 30
Study 29956424 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 30
Study 27601379 — intervention group
Group type: EXPERIMENTAL
Intervention: Trevo
Number of subjects: 500
Study 27601379 — intervention group
Group type: EXPERIMENTAL
Intervention: Solitaire
Number of subjects: 500
Study 27601379 — intervention group
Group type: EXPERIMENTAL
Intervention: Other retrievable stents or mechanical devices
Number of subjects: 500
Study 27601379 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 500
Study 27601379 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment effect
Number of subjects: 500
Study 25613830 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department-based nursing intervention (one nurse patient encounter before discharge and two phone calls in the 10 days after discharge)
Number of subjects: 203
Study 25613830 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department-based nursing intervention
Number of subjects: 203
Study 25613830 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 203
Study 23672055 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaoren Anshen capsules (five capsules)
Number of subjects: 120
Study 23672055 — intervention group
Group type: COMPARATOR
Intervention: Alprazolam (0.8 mg)
Number of subjects: 120
Study 23672055 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaoren Anshen capsules
Number of subjects: 120
Study 21362526 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory rehabilitation (n = 11)
Number of subjects: 22
Study 21362526 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 22
Study 18618870 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed and humidified insufflation (WHI)
Number of subjects: 7
Study 18618870 — intervention group
Group type: COMPARATOR
Intervention: Standard cold and dry carbon dioxide (Control)
Number of subjects: 7
Study 17005948 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel-node biopsy with immediate lymphadenectomy
Number of subjects: 1269
Study 17005948 — intervention group
Group type: COMPARATOR
Intervention: Postoperative observation of regional lymph nodes with lymphadenectomy if nodal relapse occurred
Number of subjects: 1269
Study 17005948 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel-node biopsy (tumor-positive sentinel nodes)
Number of subjects: 1269
Study 17005948 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel-node biopsy (tumor-negative sentinel nodes)
Number of subjects: 1269
Study 17005948 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate lymphadenectomy among patients with nodal metastases
Number of subjects: 1269
Study 17005948 — intervention group
Group type: COMPARATOR
Intervention: Delayed lymphadenectomy among patients with nodal metastases
Number of subjects: 1269
Study 17005948 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel-node biopsy
Number of subjects: 1269
Study 17005948 — intervention group
Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 1269
Study 17005948 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy group
Number of subjects: 1269
Study 14585899 — intervention group
Group type: EXPERIMENTAL
Intervention: CO(2)
Number of subjects: 415
Study 14585899 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 415
Study 10768622 — intervention group
Group type: EXPERIMENTAL
Intervention: Probable DLB
Number of subjects: 24
Study 10768622 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual hallucinations in DLB (n = 18)
Number of subjects: 24
Study 10768622 — intervention group
Group type: EXPERIMENTAL
Intervention: Television misidentifications in DLB (n = 5)
Number of subjects: 24
Study 8807172 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 microgram.kg‐1.min‐1 PGE1
Number of subjects: 80
Study 8807172 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg.kg‐1 lidocaine
Number of subjects: 80
Study 8807172 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 microgram.kg‐1.min‐1 PGE1
Number of subjects: 80
Study 8807172 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 80
Study 8807172 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 80
Study 1533767 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-33 ANP in 5% mannitol (0.7 microgram/min)
Number of subjects: 12
Study 1533767 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-33 ANP in 5% mannitol (1.05 micrograms/min)
Number of subjects: 12
Study 1533767 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-33 ANP in 5% mannitol
Number of subjects: 12
Study 1533767 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% mannitol)
Number of subjects: 12
Study 30141289 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming needling combined with Zhuyu Tongluo Xuebi decoction
Number of subjects: 96
Study 30141289 — intervention group
Group type: COMPARATOR
Intervention: Ciloprost (100 mg, twice a day)
Number of subjects: 96
Study 26318400 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use energy device (Ligasure 5-mm Blunt Tip LF1537 with the Force Triad generator)
Number of subjects: 46
Study 26318400 — intervention group
Group type: COMPARATOR
Intervention: Reusable bipolar forceps (RoBi 5 mm) and monopolar scissors using the same Covidien Force Triad generator
Number of subjects: 46
Study 24501094 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP38 (10 pmol/kg/min)
Number of subjects: 24
Study 24501094 — intervention group
Group type: COMPARATOR
Intervention: vasoactive intestinal polypeptide (8 pmol/kg/min)
Number of subjects: 24
Study 24501094 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP38
Number of subjects: 24
Study 24501094 — intervention group
Group type: COMPARATOR
Intervention: vasoactive intestinal polypeptide
Number of subjects: 24
Study 24377889 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine (2 mg)
Number of subjects: 258
Study 24377889 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study 20525225 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 35144
Study 18983695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dose of renal replacement therapy
Number of subjects: 0
Study 18983695 — intervention group
Group type: COMPARATOR
Intervention: Less-intensive dose of renal replacement therapy
Number of subjects: 0
Study 16896036 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 mug/d in the form of selenomethionine)
Number of subjects: 537
Study 16896036 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 537
Study 14620915 — intervention group
Group type: EXPERIMENTAL
Intervention: MUC1 detection in breast cancer tissue using three anti-MUC1 core protein MAbs (C595, HMFG2, SM3)
Number of subjects: 70
Study 14620915 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum MUC1 levels measurement through Cancer Associated Serum Antigen test and CA15-3 test
Number of subjects: 70
Study 14620915 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of IgG and IgM anti-MUC1 antibodies
Number of subjects: 70
Study 14620915 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of IgG-MUC1-CIC using C595
Number of subjects: 70
Study 14620915 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of IgM-MUC1-CIC
Number of subjects: 70
Study 14620915 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of SM3 antibody
Number of subjects: 70
Study 10970043 — intervention group
Group type: EXPERIMENTAL
Intervention: US treated wine
Number of subjects: 0
Study 10970043 — intervention group
Group type: COMPARATOR
Intervention: Non-treated white wine (CON)
Number of subjects: 0
Study 10970043 — intervention group
Group type: EXPERIMENTAL
Intervention: US treated wine (in rabbits)
Number of subjects: 0
Study 10970043 — intervention group
Group type: COMPARATOR
Intervention: Non-treated wine (CON) (in rabbits)
Number of subjects: 0
Study 9252011 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain sensation intensity
Number of subjects: 506
Study 9252011 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain unpleasantness (stage 1 affect)
Number of subjects: 506
Study 9252011 — intervention group
Group type: EXPERIMENTAL
Intervention: Suffering (stage 2 affect)
Number of subjects: 506
Study 9252011 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain behavior
Number of subjects: 506
Study 9252011 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmatory LISREL analysis
Number of subjects: 506
Study 1735489 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine transfer
Number of subjects: 42
Study 1735489 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubal embryo transfer (ET)
Number of subjects: 42
Study 1735489 — intervention group
Group type: COMPARATOR
Intervention: Uterine transfers
Number of subjects: 42
Study 1735489 — intervention group
Group type: COMPARATOR
Intervention: Tubal ETs
Number of subjects: 42
Study 6366769 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin therapy
Number of subjects: 35
Study 6366769 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 35
Study 31429355 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet modification program with increased intake of lactose, fiber, magnesium, zinc, B3, and B5; lower intake of glucose and lipid.
Number of subjects: 170
Study 31429355 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet modification program
Number of subjects: 170
Study 31327314 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 607
Study 31327314 — intervention group
Group type: COMPARATOR
Intervention: Current practice
Number of subjects: 607
Study 29031771 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting (24 hours/week, maximum caloric intake of 300 kcal on fasting days)
Number of subjects: 36
Study 29031771 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained habitual nutrition)
Number of subjects: 36
Study 27007018 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Impact
Number of subjects: 35
Study 27007018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 25375826 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention in skills of control, stimulus recognition, and phonological awareness over a 4-month period for RD+ASF group.
Number of subjects: 280
Study 25375826 — intervention group
Group type: COMPARATOR
Intervention: Intervention in skills of control, stimulus recognition, and phonological awareness over a 4-month period for RD group.
Number of subjects: 280
Study 25375826 — intervention group
Group type: COMPARATOR
Intervention: Intervention in skills of control, stimulus recognition, and phonological awareness over a 4-month period for RL group.
Number of subjects: 280
Study 22503654 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined counseling and progressive resistance home-exercises
Number of subjects: 108
Study 22503654 — intervention group
Group type: COMPARATOR
Intervention: Counseling, balance-training and support from the physical therapist (Control group)
Number of subjects: 108
Study 22503654 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Intervention and Control)
Number of subjects: 108
Study 19858141 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (antihypertensive medication)
Number of subjects: 51
Study 19858141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 16965225 — intervention group
Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAMe) monotherapy 500 mg twice daily in slow running infusion for twelve days followed by oral administration of 500 mg twice daily until delivery
Number of subjects: 78
Study 16965225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) monotherapy 3x250 mg daily
Number of subjects: 78
Study 16965225 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of UDCA and SAMe
Number of subjects: 78
Study 14653123 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 55
Study 14653123 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin
Number of subjects: 55
Study 14653123 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 55
Study 11009047 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg b.i.d.) with mirtazapine (30 mg nocte)
Number of subjects: 12
Study 11009047 — intervention group
Group type: COMPARATOR
Intervention: Placebo with mirtazapine (30 mg nocte)
Number of subjects: 12
Study 9611400 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal TSH values in Salazie
Number of subjects: 294
Study 9611400 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of goiter
Number of subjects: 294
Study 9611400 — intervention group
Group type: EXPERIMENTAL
Intervention: Median urinary iodine levels
Number of subjects: 294
Study 9611400 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of milk and dairy products
Number of subjects: 294
Study 8406286 — intervention group
Group type: EXPERIMENTAL
Intervention: Etofibrat
Number of subjects: 55
Study 8406286 — intervention group
Group type: COMPARATOR
Intervention: Other lipid-lowering agents
Number of subjects: 55
Study 8406286 — intervention group
Group type: COMPARATOR
Intervention: No further medication
Number of subjects: 55
Study 2949396 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 500 mg b.i.d. for 14 days
Number of subjects: 25
Study 2949396 — intervention group
Group type: COMPARATOR
Intervention: Placebo b.i.d. for 14 days
Number of subjects: 25
Study 2949396 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 25
Study 2949396 — intervention group
Group type: COMPARATOR
Intervention: Healthy males (matched age)
Number of subjects: 25
Study 31712838 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided corticosteroid injection
Number of subjects: 44
Study 31712838 — intervention group
Group type: COMPARATOR
Intervention: Palpation-guided corticosteroid injection
Number of subjects: 44
Study 30226342 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg/kg/h)
Number of subjects: 52
Study 30226342 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 52
Study 28230732 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoid-rich blueberry drink
Number of subjects: 71
Study 28230732 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 71
Study 26634183 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine small intestine submucosa (SIS)
Number of subjects: 82
Study 26634183 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 82
Study 24289490 — intervention group
Group type: EXPERIMENTAL
Intervention: Tutored PBL
Number of subjects: 0
Study 24289490 — intervention group
Group type: COMPARATOR
Intervention: Tutorless PBL
Number of subjects: 0
Study 21074212 — intervention group
Group type: EXPERIMENTAL
Intervention: Index tumor volume threshold of 0.5 ml
Number of subjects: 325
Study 21074212 — intervention group
Group type: EXPERIMENTAL
Intervention: Index tumor volume threshold after accounting for tumor stage and grade
Number of subjects: 325
Study 21074212 — intervention group
Group type: EXPERIMENTAL
Intervention: Total tumor volume threshold
Number of subjects: 325
Study 21074212 — intervention group
Group type: EXPERIMENTAL
Intervention: Total tumor volume threshold after accounting for tumor stage and grade
Number of subjects: 325
Study 20552850 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum three times per day
Number of subjects: 0
Study 20552850 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucking on hard candy three times per day
Number of subjects: 0
Study 20552850 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 17233236 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum in combination with counseling (motivational interviewing or health education)
Number of subjects: 755
Study 17233236 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum in combination with counseling (motivational interviewing or health education)
Number of subjects: 755
Study 15731509 — intervention group
Group type: EXPERIMENTAL
Intervention: Aban Aya Youth Project
Number of subjects: 552
Study 15731509 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 552
Study 12789991 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Simply White Clear Whitening Gel (18% carbamide peroxide)
Number of subjects: 141
Study 9798802 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride (1.2 mg)
Number of subjects: 9
Study 9798802 — intervention group
Group type: EXPERIMENTAL
Intervention: Biperiden (5 mg)
Number of subjects: 9
Study 9798802 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 9
Study 7636454 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan (6 mg per dose, one or two doses for a single migraine episode)
Number of subjects: 648
Study 7636454 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan
Number of subjects: 648
Study 7636454 — intervention group
Group type: COMPARATOR
Intervention: Aspirin and Acetaminophen
Number of subjects: 648
Study 2197532 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg pentamidine in 6 ml Aqua dest. with Inspiratory vital capacity breathing
Number of subjects: 6
Study 2197532 — intervention group
Group type: EXPERIMENTAL
Intervention: Portasonic nebulizer
Number of subjects: 6
Study 2197532 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg pentamidine in 6 ml Aqua dest.
Number of subjects: 6
Study 2197532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic nebulization
Number of subjects: 6
Study 2197532 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory vital capacity breathing (12/min)
Number of subjects: 6
Study 318710 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadyl acetate, dispensed three times per week
Number of subjects: 0
Study 318710 — intervention group
Group type: COMPARATOR
Intervention: Methadone, dispensed six days per week
Number of subjects: 0
Study 318710 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadyl acetate
Number of subjects: 0
Study 318710 — intervention group
Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 0
Study 31081480 — intervention group
Group type: EXPERIMENTAL
Intervention: dual‐disorder treatment of PTSD and SUD using prolonged exposure
Number of subjects: 107
Study 31081480 — intervention group
Group type: EXPERIMENTAL
Intervention: single‐disorder relapse prevention treatment for SUD
Number of subjects: 107
Study 31081480 — intervention group
Group type: COMPARATOR
Intervention: active monitoring control group
Number of subjects: 107
Study 31081480 — intervention group
Group type: EXPERIMENTAL
Intervention: African Americans compared to Whites
Number of subjects: 107
Study 31081480 — intervention group
Group type: EXPERIMENTAL
Intervention: Religious affiliation
Number of subjects: 107
Study 27880052 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided BoNT‐A injections
Number of subjects: 30
Study 27880052 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyographic guided BoNT‐A injections
Number of subjects: 30
Study 27880052 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 25987410 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular (BIV) stimulation
Number of subjects: 28
Study 25987410 — intervention group
Group type: COMPARATOR
Intervention: Left ventricular (LV) stimulation
Number of subjects: 28
Study 23768769 — intervention group
Group type: EXPERIMENTAL
Intervention: Large defect width
Number of subjects: 865
Study 23768769 — intervention group
Group type: EXPERIMENTAL
Intervention: Large defect length
Number of subjects: 865